Agreement featuring UK pharma services consultancy intends to grow PharmaLex's pan-European market access presence
PharmaLex Group, a specialized services source for the pharma, biotech, and medtech industries, is merging with NeoHealthHub Limited, a UK pharmaceutical and healthcare services consultancy.
The agreement with NeoHealthHub (NHH), which is expected to close at the end of the month, works toward the goal of building a pan-European market access practice covering major markets, including the UK, Germany, Italy, Spain, France, and the Nordics. NHH supports its customers by offering innovative and comprehensive market access, data, and capability development solutions across all phases of the pharma and healthcare brand lifecycle through its four business units, NeoNavitas, NeoN, NeoSypher, and NeoOptima.
“The merger is a good strategic fit for NHH because we share similar values and corporate culture with PharmaLex, built on an entrepreneurial spirit,” says NHH CEO Simon Doyle. “Both our organizations support a model of thinking global but acting local, which for us means responding to the unique and complex needs of the pharmaceutical and healthcare marketplace. We have created an organization and structure that allows us to operate in a truly agile way, maximizing opportunities as they emerge. Through the merger, we will be able to build on those opportunities and offer extended services and expertise to our clients, while further expanding the client base.”